LTRN
Lantern Pharma·NASDAQ
--
--(--)
--
--(--)
5.42 / 10
Netural
Fund-flow analysis shows a good score (7.38/10) with positive overall and block inflows, suggesting institutional interest despite negative Small and Medium flows. Analyst sentiment is overwhelmingly bullish (Strong Buy 100%), yet the current price decline (-7.89%) highlights a mismatch between expectations and market action, tempering the optimism.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-04-02
InstitutionLake Street
Times predicted1
Historical Win Rate100.0%
Is money flowing into or out of LTRN?
- LTRN holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 5.42/10 (Netural).
